AbCellera Biologics (ABCL) Stock Forecast
AI forecast: ABCL
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Ninghtang 6 hpeh hta rai
Premium shi AI hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe shan ai.
Unlock Premium🔒 Ninghkang hpe hkum hkum hpe hta
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumNinghpaw hta mung
AbCellera Biologics Inc. operates as a pharmaceutical company. The company researches and develops next-generation therapeutic antibodies using a combination of technologies, including patented immunizations, microfluidics, high-throughput imaging, genomics, computing, and laboratory automation. AbCellera Biologics serves customers in Canada.
